Wells Fargo Upgrades Inari Medical Inc. (NARI) to Overweight
- Wall St ends up with Goldman; Dow posts biggest weekly rise since June
- Goldman Sachs (GS) Smashes Analyst 3Q Views on Robust M&A and Underwriting Activity
- Tesla (TSLA) Stock: Jefferies Raises Price Target on Higher Capacity Ramp and Sustained Demand, Berlin Giga Will Set New Design and Assembly Standards Says Analyst
- Food, fuels lift U.S. import prices in September
- SEC to Allow First Ever Bitcoin (BTC) ETF - Report
Wells Fargo analyst Lawrence Biegelsen upgraded Inari Medical Inc. (NASDAQ: NARI) from Equal Weight to Overweight with a price target of $79.00.
Shares of Inari Medical Inc. closed at $66.41 yesterday.
You May Also Be Interested In
- Semiconductor Stocks: Prepare for Mixed 3Q Results/Guidance Says Goldman Sachs and Upgrades Broadcom (AVGO) to Buy and Downgrades Western Digital (WDC) to Neutral
- Berenberg Upgrades Kosmos Energy (KOS) to Buy
- ODDO BHF Upgrades Euronav (EURN) to Outperform
Create E-mail Alert Related CategoriesUpgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!